Get the Stockscreener App
1.04
0.00%
0.00
Calidi Biotherapeutics Inc stock is traded at $1.04, with a volume of 91,273.
It is up +0.00% in the last 24 hours and down -20.00% over the past month.
Calidi Biotherapeutics Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is headquartered in San Diego, California.
See More
Previous Close:
$1.04
Open:
$1.05
24h Volume:
91,273
Relative Volume:
0.71
Market Cap:
$7.45M
Revenue:
-
Net Income/Loss:
$-23.36M
P/E Ratio:
-1.4115
EPS:
-0.7368
Net Cash Flow:
-
1W Performance:
-9.57%
1M Performance:
-20.00%
6M Performance:
-86.29%
1Y Performance:
-90.32%
1-Day Range:
$1.01
$1.09
1-Week Range:
$1.01
$1.16
52-Week Range:
$1.01
$19.20
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Name
Calidi Biotherapeutics Inc
Sector
Industry
Phone
(858) 794-9600
Address
4475 Executive Drive, Suite 200, San Diego
Compare CLDI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
1.04 | 7.45M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.93 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
731.00 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
801.63 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
358.61 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.06 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-23 | Initiated | H.C. Wainwright | Buy |
| Oct-09-23 | Initiated | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Stock (CLDI) Latest News
Merger Talk: What is the fair value of Calidi Biotherapeutics Inc stock nowDip Buying & Daily Entry Point Alerts - Bộ Nội Vụ
What catalysts could drive Calidi Biotherapeutics Inc. stock higher2025 Short Interest & Accurate Buy Signal Alerts - Улправда
Will Calidi Biotherapeutics Inc. stock gain from green policiesDollar Strength & Weekly Stock Breakout Alerts - Улправда
How sustainable is Calidi Biotherapeutics Inc. stock dividend payoutProfit Target & Daily Momentum Trading Reports - Улправда
Will Calidi Biotherapeutics Inc. stock outperform global peersQuarterly Earnings Summary & Technical Confirmation Trade Alerts - Улправда
How Calidi Biotherapeutics Inc. stock reacts to Fed rate cutsQuarterly Risk Review & Community Trade Idea Sharing Platform - Улправда
Why Calidi Biotherapeutics Inc. stock is rated strong buyJuly 2025 Momentum & AI Optimized Trade Strategies - Улправда
How risky is Calidi Biotherapeutics Inc. stock nowSmall Cap Stock Opportunities & Watch and Learn From Live Trades - ulpravda.ru
United States Oncolytic Viral Therapy Market to hit US$ 164.51 - openPR.com
Will Calidi Biotherapeutics Inc. stock issue positive guidance2026 world cup usa national team third place match playmakers pressing system group prediction tactical review - ulpravda.ru
Calidi Biotherapeutics sinks after pricing $3.9M registered direct offering - MSN
Will Calidi Biotherapeutics Inc. stock outperform international peersEarnings Miss Alerts & Affordable Trading Portfolio - bollywoodhelpline.com
Retail Surge: Will Calidi Biotherapeutics Inc stock outperform international peersJuly 2025 Drop Watch & Fast Gain Swing Trade Alerts - moha.gov.vn
Is Calidi Biotherapeutics Inc. stock positioned for long term growthDebt-to-Equity Ratio Analysis & Free Unlock Rapid Growth Potential - Bollywood Helpline
Bearish Setup: Will Calidi Biotherapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Levels & Weekly Stock Breakout Alerts - Улправда
Calidi Biotherapeutics Earnings Notes - Trefis
Is Calidi Biotherapeutics Inc. stock a smart buy before Fed meeting2025 Support & Resistance & Free Daily Entry Point Trade Alerts - DonanımHaber
Is Calidi Biotherapeutics Inc. stock inflation resilientJuly 2025 Analyst Calls & High Conviction Buy Zone Alerts - DonanımHaber
Will Calidi Biotherapeutics Inc. stock benefit from upcoming earnings reportsWeekly Profit Summary & Stock Portfolio Risk Control - Улправда
Aug Weekly: How risky is Calidi Biotherapeutics Inc. stock nowJuly 2025 PreEarnings & AI Forecast Swing Trade Picks - Улправда
Rally Mode: How risky is Calidi Biotherapeutics Inc. stock nowDollar Strength & Real-Time Sentiment Analysis - Улправда
Calidi Biotherapeutics (CLDI) director details estate-planning share sale - Stock Titan
Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Cape Cod Times
Why retail investors favor Calidi Biotherapeutics Inc. stockQuarterly Growth Report & Long-Term Capital Growth Ideas - Newser
Why Calidi Biotherapeutics Inc. stock stays on top picksOil Prices & Free Technical Confirmation Trade Alerts - Newser
Will Calidi Biotherapeutics Inc. stock outperform benchmarksQuarterly Portfolio Report & High Accuracy Buy Signal Tips - Newser
Will Calidi Biotherapeutics Inc. stock outperform small cap peersPortfolio Risk Report & Real-Time Volume Spike Alerts - Newser
Will Calidi Biotherapeutics Inc. stock rally after Fed decisions2025 Historical Comparison & Fast Gain Stock Trading Tips - Newser
Is Calidi Biotherapeutics Inc. stock supported by strong fundamentals2025 Price Action Summary & Fast Entry Momentum Alerts - Newser
How analysts revise price targets for Calidi Biotherapeutics Inc. stockTrade Exit Summary & Safe Capital Investment Plans - Newser
Will Calidi Biotherapeutics Inc. stock split increase liquidityShare Buyback & Growth Focused Stock Reports - Newser
Calidi Biotherapeutics Inc Stock (CLDI) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.37%
1.44%
Cap:
|
Volume (24h):